European Shorting
To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2012-10-15 | Sell | 6,500 | $52.93 | 344 | 50.18 | 0.00 | 132.60 | 17244.9 |  Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2012-09-17 | Sell | 6,500 | $57.52 | 373.9 | 38.2 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2012-08-15 | Sell | 6,500 | $54.13 | 351.8 | 46.85 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2012-07-16 | Sell | 6,500 | $52.78 | 343.1 | 50.61 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2012-06-15 | Sell | 6,500 | $56.37 | 366.4 | 41.01 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2012-05-15 | Sell | 6,500 | $64.28 | 417.8 | 23.66 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2012-05-07 | Sell | 79,500 | $53.03 | 4215.9 | 49.9 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2011-09-20 | Sell | 25,000 | $52.5 | 1312.5 | 51.41 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2011-09-15 | Sell | 9,500 | $50.19 | 476.8 | 58.38 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2011-08-29 | Sell | 9,500 | $45.01 | 427.6 | 76.61 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2011-07-15 | Sell | 2,500 | $50.68 | 126.7 | 56.85 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2011-05-16 | Sell | 2,500 | $57.02 | 142.6 | 39.41 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2011-04-25 | Sell | 12,500 | $50 | 625 | 58.98 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2011-04-15 | Sell | 2,500 | $47.49 | 118.7 | 67.38 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2011-04-11 | Sell | 40,000 | $48.03 | 1921.2 | 65.5 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-11-15 | Sell | 1,600 | $34.43 | 55.1 | 130.87 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-10-15 | Sell | 1,600 | $35.65 | 57 | 122.97 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-09-15 | Sell | 1,600 | $37.22 | 59.6 | 113.57 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-08-16 | Sell | 1,600 | $36.38 | 58.2 | 118.5 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-07-15 | Sell | 1,600 | $34.24 | 54.8 | 132.16 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-06-15 | Sell | 1,600 | $34.93 | 55.9 | 127.57 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-05-17 | Sell | 1,600 | $37.39 | 59.8 | 112.6 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-05-07 | Sell | 6,271 | $35.97 | 225.6 | 120.99 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-04-15 | Sell | 1,600 | $39.61 | 63.4 | 100.68 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-03-15 | Sell | 1,600 | $43.08 | 68.9 | 84.52 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-02-16 | Sell | 1,600 | $38.55 | 61.7 | 106.2 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-02-03 | Sell | 3,844 | $40.07 | 154 | 98.38 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP, Global R&D, CSO | 2010-01-26 | Sell | 2,026 | $39.39 | 79.8 | 101.8 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP Global R&D, CSO | 2010-01-15 | Sell | 1,600 | $40.32 | 64.5 | 97.15 | 0.00 | 132.60 | 17244.9 | Link |
| VRTX | Vertex Pharmace... | MUELLER PETER | EVP Global R&D, CSO | 2009-12-04 | Sell | 1,600 | $39.62 | 63.4 | 100.63 | 0.00 | 132.60 | 17244.9 | Link |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Vanguard Health Care Fund | 2013-03-31 | 2,489,800 | 0.54% | +10.97% | |
| Pioneer Investments | 2013-03-31 | 2,422,523 | 0.53% | -0.66% | |
| Andreas Halvorsen | 2013-03-31 | 780,500 | 0.26% | New Buy | |
| NWQ Managers | 2013-03-31 | 191,032 | 0.09% | -23.44% | |
| Jim Simons | 2013-03-31 | 137,417 | 0.02% | New Buy | |
| Steven Cohen | 2013-03-31 | 13,529 | 0% | New Buy | |
| Louis Moore Bacon | 2013-03-31 | 0 | 0% | Sold Out | |
 Most recent portfolio changes are included for Premium Members only!
| |||||
Feedback
My Portfolios
Browse Gurus
Insider Trade Rss Update
Bookmark
This page has been successfully added into your 
RSS
Add Notes, Comments or Ask Questions
Comments